Medibio Ltd. provides protocols for the diagnosis and reinforcement of therapies for the treatment and prevention of mental health issues. The company operates its business in two segments: Mining and Gas Exploration; and Human Diagnostics. The Mining and Gas Exploration segment includes the income and expenditures pertaining to the investment opportunity through Frontier Oil. The Human Diagnostics segment includes the income and expenditures pertaining to the investment opportunity through Invatec Health. Medibio was founded in 1998 and is headquartered in South Yarra, Australia.
|Market Price at 24-11-2017||$0.36|
|Price to Earnings Ratio||-4.95|
|Market Capitalisation||$52.80 (million)|
|Return on Equity (ROE)||-71.83%|